Pattern of drug utilization and factors influencing long term blood sugar control among diabetics in a tertiary care hospital- an observational study
DOI:
https://doi.org/10.18203/2319-2003.ijbcp20171672Keywords:
Diabetes, Drug utilization, Observational study, Prescription patternAbstract
Background: To study the Pattern of drug prescribing, utilization, analyse effectives of different therapies and factors influencing medication failure and adherence to treatment among diabetics.
Methods: The clinical study was conducted in JJM Medical College and Karuna Trust, Davangere, Karnataka. The patients with diabetes as diagnosed by consultant physician were observed for the pattern of blood glucose control. The fasting blood glucose of the patients were recorded at the end of 1st month, 6th month and 12th month of their treatment period. The study period was from June 2012 till August 2014. The study was conducted after institutional ethical clearance and informed consent was taken from all the patients. The pattern of drugs prescribed for the patients were also analysed. The pattern of control among patients with co morbidities were also analysed using paired sample t test.
Results: The results showed that the prescribed drugs were able to control the blood glucose levels of the patients. The percentage of patients with FBS in controlled, mild to moderate control and uncontrolled group were 21%, 33.3% and 45.5% in early treatment period and 36%, 40.9%, and 22.7% after one year treatment period (Significant p value). The pattern of drug utilization showed that the most commonly used drugs were the combination of pioglitazone+glimipride+metformin (19%), combination of glibenclamide+ metformin (18%), only insulin (9%), combination of glimipride+metformin (8%) and combination of gliclazide+metformin (5%).
Conclusions: The results show that the intervention by the consultant physician was successful in controlling the blood sugar levels and the reasons for failure of treatment and adherence to treatment were helpful for further treatment of patients. Further such studies in a larger sample will help the consultants in their treatment methods.
References
Khan GH, Aqil M, Pillai KK, Ahmad MA, Kapur P, Ain MR et al. Therapeutic adherence: A prospective drug utilization study of oral hypoglycemic in patients with type 2 diabetes mellitus. Asian J Trop Dis. 2014;4:347-52.
Sivasankari V, Manivannan E, Priyadarshini PS. Drug utilization pattern of anti-diabetic drugs in a rural area of Tamilnadu, South India- a prospective, observational study. Int J Pharm Bio Sci. 2013;4:514-19.
Kaveeshwar SA, Cornwall J. The current state of diabetes mellitus in India. AMJ. 2014;7:45-8.
Gaikwad A, Kanitkar S, Kalian M, Tamakuwala K, Agarwal R, Bhimavarapa B. Prevalence of type 2 diabetes mellitus in candidates contesting for municipal corporation elections in an urban industrialized town. Indian J Basic Appl Med Res. 2014;3:412-18.
Sajith M, Pankaj M, Pawar A, Modi A, Sumariya R. Medication adherence to antidiabetic therapy in patients with type 2 diabetes mellitus. Int J Pharm Pharm Sci. 2014;6:564-70.
World Health Organization. Global Report on Diabetes. Isbn [Internet]. 2016:978-80 Available from: http://www.who.int/about/licensing/nhttp://apps.who.int/iris/bitstream /10665/ 204871/1/9789241565257_eng.pdf
Cdc. A Public Health Action Plan to Prevent Heart Disease and Stroke. 2010; Available from: http://www.cdc.gov/dhdsp/action_plan/pdfs/action_plan_full.pdf
Matheus ASDM, Tannus LRM, Cobas RA, Palma CCS, Negrato CA, Gomes MDB. Impact of diabetes on cardiovascular disease: An update. Int J Hypertens. 2013;2013.
Panikar V, Chandalia HB, Joshi SR, Fafadia A, Santvana C. Beneficial effects of triple drug combination of pioglitazone with glibenclamide and metformin in type 2 diabetes mellitus patients on insulin therapy. J Assoc Physicians India. 2003;51:1061-4.
Kannan, Arshad, Kumar S. A study on drug utilization of oral hypoglycemic agents in type-2 diabetic patients. Asian J Pharm Clin Res. 2011;4(4):60-4.
Polonsky WH. Poor medication adherence in diabetes: What’s the problem ? J Diabetes. 2015;7:777-8.
